Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

18 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

AltheRx Pharma Articles

AltheRx buys GSK mid-stage cast-off OAB/IBS drug solabegron

29 March 2011

Showing 1-1 of 1 articles

Go to beginning

Previous

1

Next

Go to end

Hot Topics
Most Read

Encouraging results with Sangamo's SB-728-T in HIV treatment
Bristol-Myers' data on Yervoy and nivolumab causes a stir
AstraZeneca plans to move three cancer drug candidates into Ph III
Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

Encouraging results with Sangamo's SB-728-T in HIV treatment
Bristol-Myers' data on Yervoy and nivolumab causes a stir
AstraZeneca plans to move three cancer drug candidates into Ph III
Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS